It is truly amazing what technology is doing for the health care industry. I came across an article today highlighting a technological advancement in the detection of Alzheimer’s.
U.S. researches have developed a test that may detect Alzheimer’s disease in the blood. The technology they created looks for specific antibodies in the blood that are produced in response to a disease, like Alzheimer’s. Research is suggesting that instead of attacking the disease, these antibodies are attacking cells that have been altered as a result of the disease.
A study of the technology showed that it accurately spotted Alzheimer’s in the blood samples of 6 patients with the disease. A similar study performed on 200 people without the disease found that approximately 8% of them had elevated concentrations of the same antibodies found in Alzheimer’s patients, suggesting that the test could be used as an early predictor of the disease.
Thomas Kodadek of the Scripps Research Institute in Jupiter, Florida, has licensed the technology to Miami-based OPKO Health Inc, which will develop diagnostic kits, thus making it more readily available to pharmaceutical companies.
The results of the test, although preliminary, provide hope for the treatment and prevention of Alzheimer’s. Kodadek is optimistic that the approach could be used to detect for other diseases, such as cancer, Parkinson’s, multiple sclerosis and lupus.